image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Glisten - Fast growing niche food group

August 2002

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • GLI
Glisten is a new company formed to create, via its "buy and build" acquisition strategy, a portfolio of foods businesses in niche markets.  Its goal is to grow  annual sales to over £100m over the next few years.  This might seem ambitious, especially since it implies sales growing seven-fold from the current base of £13.8m. Shares in food producers are enjoying something of are naissance right now as investors search for companies that can produce steady and reliable growth in markets where demand is unlikely to fall off a cliff.  Shares in Glisten currently trade on a forward PE of 7.0 compared to the sector average of 15.8 and part of the reason for this is that Glisten is a new company without an established track record. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X